1. Home
  2. TTI vs OGN Comparison

TTI vs OGN Comparison

Compare TTI & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tetra Technologies Inc.

TTI

Tetra Technologies Inc.

N/A

Current Price

$11.02

Market Cap

1.5B

Sector

Energy

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$7.94

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TTI
OGN
Founded
1981
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
TTI
OGN
Price
$11.02
$7.94
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$10.40
$11.63
AVG Volume (30 Days)
1.4M
4.6M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
1.01%
EPS Growth
310.00
N/A
EPS
0.15
1.50
Revenue
N/A
$6,403,000,000.00
Revenue This Year
$5.43
N/A
Revenue Next Year
$4.18
$1.65
P/E Ratio
$73.28
$5.32
Revenue Growth
N/A
2.24
52 Week Low
$2.03
$6.18
52 Week High
$12.54
$16.12

Technical Indicators

Market Signals
Indicator
TTI
OGN
Relative Strength Index (RSI) 51.04 51.83
Support Level $10.48 $6.48
Resistance Level $12.40 $10.40
Average True Range (ATR) 0.61 0.38
MACD -0.11 0.00
Stochastic Oscillator 30.56 80.30

Price Performance

Historical Comparison
TTI
OGN

About TTI Tetra Technologies Inc.

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: